TFF Pharmaceuticals, Inc.

TFFP · NASDAQ
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Activities
Net Income-$21,243-$31,770-$31,039-$18,567
Dep. & Amort.$502$388$111$0
Deferred Tax-$38-$5,038-$6,189$0
Stock-Based Comp.$2,926$4,252$3,548$2,187
Change in WC$1,526-$212-$2,178-$236
Other Non-Cash$289$5,038$6,189$1,324
Operating Cash Flow-$16,038-$27,342-$29,557-$16,616
Investing Activities
PP&E Inv.-$95-$1,551-$869-$1,103
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$95-$1,551-$869-$1,103
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$5,125$11,640$28,015$24,280
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$109$111$870$714
Financing Cash Flow$5,013$11,751$28,885$24,995
Forex Effect-$15-$40$34-$70
Net Chg. in Cash-$11,134-$17,182-$1,506$7,206
Supplemental Information
Beg. Cash$16,612$33,795$35,301$28,095
End Cash$5,478$16,612$33,795$35,301
Free Cash Flow-$16,133-$28,893-$30,425-$17,718